Fig. 5From: Screening potential immune signatures for early-stage basal-like/triple-negative breast cancerThe expression validation of GAL and TTC36 in early-stage basal-like/triple-negative breast cancer. A GAL expression. B TTC36 expression. TNBC, triple-negative breast cancerBack to article page